0001104659-21-128645.txt : 20211021 0001104659-21-128645.hdr.sgml : 20211021 20211021205057 ACCESSION NUMBER: 0001104659-21-128645 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211021 FILED AS OF DATE: 20211021 DATE AS OF CHANGE: 20211021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Merck KGaA CENTRAL INDEX KEY: 0001764133 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 211338457 BUSINESS ADDRESS: STREET 1: FRANKFURTER STR. 250 CITY: DARMSTADT STATE: 2M ZIP: 64293 BUSINESS PHONE: 004961517245950 MAIL ADDRESS: STREET 1: FRANKFURTER STR. 250 CITY: DARMSTADT STATE: 2M ZIP: 64293 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 3 1 tm2130646-14_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2021-10-21 0 0001840233 Xilio Therapeutics, Inc. XLO 0001764133 Merck KGaA FRANKFURTER STRASSE 250 DARMSTADT 2M 64293 GERMANY 0 0 1 0 Series B Preferred Stock Common Stock 416060 I See footnote Series C Preferred Stock Common Stock 264765 I See footnote The Series B Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. The shares are held directly by Merck Ventures B.V. Merck Ventures B.V. is a wholly owned indirect subsidiary of Merck KGaA, a publicly traded company. Merck KGaA may be deemed to have sole voting and dispositive power with respect to the shares held by Merck Ventures B.V. The Series C Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. /s/ Christian Uhrich, Authorized signatory of Merck KGaA, Darnstadt, Germany 2021-10-21 /s/ Dr. Melanie Eckhardt, Authorized signatory of Merck KGaA, Darnstadt, Germany 2021-10-21